AIRWAY VISTA
Home > 연구원 활동 > AIRWAY VISTA
Airway Vista는 2008년 3월에 처음 개최된 이후 매년 세계의 선구적 역할을 하는 석학이 참여하여 폐쇄성폐질환에 대한
최신 지견을 발표하고 토론하는 학술의 장이 되고 있습니다.
▶홈페이지 바로가기
1. 목적: 폐쇄성폐질환 최신 지식 교류 및 연구 활성화
대내적 : 의학계 인식 전환
COPD, 중증 천식이 난치병이 아니라 치료 가능한 가역적인 병으로 인식을 전환하기 위해
노력하고 있으며 COPD 및 중증 천식 임상연구 중요성 홍보를 통한 연구 활성화에 앞장서고 있습니다.
대외적 : 아시아권 COPD 공동연구 제안
서구 석학들에게 국내 연구 수준과 결과를 홍보하고 참여한 아시아 석학들에게 공동연구 네트워크를 제안하여
‘폐쇄성폐질환 아시아 네트워크’를 발족시키 되었습니다.
2. 기대효과
난치병으로 알려진 COPD와 천식의 진단 및 치료 등 의학적 지식을 확산, 보급하며 새로운 치료법을 소개하여
전문의학자, 임상의사 및 기타 의료 종사자들에게 COPD와 중증 천식을 치료할 수 있다는 희망을 제시하고 있습니다.
Introduction
The Airway Vista is hosted by the Clinical Research Center for Chronic Obstructive Airway Diseases that has been supported
by the Asan Medical Center, Seoul and by the Ministry of Health & Welfare, South Korea. Since 2008, we have successfully held
the Airway Vista annually which had more than twentyfive speakers and audience of approximately five hundreds.
This academic occasion aims to provide respiratory professionals with new horizons in understanding chronic obstructive airway diseases
COPD and asthma. It is our belief that it assures to be a premier forum for generating thoughtprovoking discussion on pathogenesis
evaluation, imaging, systemic aspects, exacerbation, heterogeneity, and new treatments of the ailment.
Program Overview
March 23(SAT), 2024 | |||
09:00-09:05 | Welcome Message from Chairman of Obstructive Lung Disease Research Foundation | ||
09:05-09:10 | Congratulatory Message from the President of the Korean Academy of Asthma, Allergy and Clinical Immunology |
Grand Auditorium | |||
Plenary Session: GINA, GOLD, and More (English) - Yeon-Mok Oh | |||
09:10-09:35 | Helen K. Reddel: Global Strategy for Asthma Management | ||
09:35-10:00 | Gerard Criner: GOLD Update 2024 (Virtually) | ||
10:00-10:25 | Gerard Criner: Interventional Treatments for COPD (Virtually) | ||
10:25-10:45 | Yeon-Mok Oh: Lung Regeneration Strategies for the Treatment of Emphysema | ||
10:45-11:00 | Break |
Grand Auditorium | Auditorium | ||
Precision Medicine (English) - An Soo Jang | COPD (Korean) - Sei Won Lee | ||
11:00-11:20 | Ian Adcock: Radiomultiomics: Linking Cellular Function to HRCT Imaging | 11:00-11:25 | Hyun Woo Lee: Emerging Pharmacologic Therapies on the Horizon of COPD Treatment |
11:20-11:40 | Fan Chung: The Variegate Molecular Endotypes of Severe Asthma from U-BIOPRED | 11:25-11:50 | Se Hee Lee: Microbiome Matters: Current Understanding and Future Prospects in COPD |
11:40-12:00 | Helen K. Reddel: Towards Precision Medicine in Asthma and COPD | 11:50-12:15 | Jieun Kang: Guidance for Managing Air Pollution Exposure in Patients with COPD |
12:00-12:20 | Sun Kim: Gene-level Biomarker Discovery from Multi-Omics Data Using Graph ATtention Neural Network for Asthma | 12:15-12:40 | Chiwook Chung: Recent Approaches of Digital Therapeutics in COPD - Impending Transformation |
12:20-12:40 | Philip Bardin: Real-world Evidence for OCS Reduction Using Biological Therapies in Severe Asthma - the Role of OCS Stewardship (Sponsored by GSK) | ||
12:40-13:50 | Lunch Break |
Discussion on hot issues of COPD and Asthma (English) - Sei Won Lee/Heung Woo Park |
Asthma (Korean) - Jaechun Lee | ||
---|---|---|---|
13:50-14:15 | Jieun Kang(Hye Yun Park/Ji Ye Jung): COPD Etiotypes and their Implication | 13:50-14:15 | Min Hye Kim: Clinical Predictors of Treatment Response to Tiotropium Add-on Therapy in Adult Asthmatic Patients: From Multicenter Real-world Cohort Data in Korea |
14:15-14:40 | Sungho Won(Woo Jin Kim/Jin Hwa Lee): How can we detect COPD-G and stratify the Risk of it for the Development and Progression of COPD | 14:15-14:40 | Ga Young Ban: Biomarkers in Aspirin-exacerbated Respiratory Disease |
14:40-15:05 | Mi-Ae Kim(Ji-Yong Moon/Taehoon Lee): Asthma Remission: Is it an Achievable Goal or not? | 14:40-15:05 | Han Ki Park: What Happen to the Gut Mucosal Immunity and Gut Microbiota in Patients with T2 Asthma? |
15:05-15:30 | Sae Hoon Kim(Jae-Woo Kwon/Sang Min Lee): Non-eosinophilic Asthma : Clinical Issues for Optimizing Management | 15:05-15:30 | Hyun Lee: How to Evaluate and Treat Patients with Both Asthma and Bronchiectasis |
15:30-15:45 | Break |
Novel Concepts in the Mechanism of Airway Diseases (English) - You Sook Cho | |
---|---|
15:45-16:05 | Ian Adcock: The Role of IL-33 in Non-T2 Obstructive Lung Disease |
16:05-16:25 | Fan Chung: The Microbiome of Severe Asthma: Importance of Bacterial Species Overgrowths |
16:25-16:40 | Break |
Molecular Subtyping of Asthma in COREA : RNA-seq Based Clustering Approach – Tae-Bum Kin/Fan Chung |
|
---|---|
16:40-16:50 | Duong Duc Pham: Interesting Clinical Findings from PRISM Study |
16:50-17:00 | So-Young Park: Molecular Phenotyping of Asthma Using Serum Transcriptomics in COREA |
17:00-17:10 | Jin An: Mucin and Biologics : Findings from Pre and Post CT Scans |
17:10-17:20 | Ga Young Ban: Multi-omics Meta Analysis for Asthma Clusters |
17:20-17:30 | Ji-Hyang Lee: scRNA Sequencing Reveals Hidden Secrets in Biologics Therapy |
17:30-17:40 | Han Ki Park: EV based Microbiome Biomarkers in Severe Asthma Patients Treated with Biologics: EBC and Stool |
17:40-17:45 | Closing |
Speaker